TABLE 1.
Reference | Type of lymphoma | Inhibited factor | Bleeding at presentation | Clinical Outcome |
---|---|---|---|---|
Gesierich 2000 [2] | CLL | VIII | Cutaneous | N/A |
Rungjirajittranon 2021 [8] | LPL | X | Menorrhagia | Remission |
Aljohani 2014 [4] | MCL | V | Hematuria | N/A |
Nixon 2016 [6] | MCL | XIII | Menorrhagia | Remission |
Meenhuis 2015 [5] | MZL | X | Cutaneous | Remission |
Naismith 2021 [7] | MZL | VII | None | Remission |
Lee 2001 [3] | N/A | II | Cutaneous | Remission |
Goyal 2022* | PCNSL | VII | None | Death |
Refers to the case being presented in this report.
Abbreviations: CLL, chronic lymphocytic leukemia; LPL, lymphoplasmacytic lymphoma; MCL, mantle cell lymphoma; MZL, marginal zone lymphoma; N/A, not available; PCNSL, primary central nervous system lymphoma.